SYSTEMIC LUPUS ERTHEMATOSUS (SLE)
Clinical trials for SYSTEMIC LUPUS ERTHEMATOSUS (SLE) explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERTHEMATOSUS (SLE) trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERTHEMATOSUS (SLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cells engineered to fight lupus enter first human tests
Disease control Not yet recruitingThis early-stage trial tests a new treatment called KN5501 for people with moderate to severe lupus that hasn't responded to standard therapies. The treatment uses specially engineered immune cells (CAR-NK cells) to target and destroy faulty B cells that drive the disease. Partic…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS (SLE)
Phase: PHASE1 • Sponsor: Ruitherapeutics Co., LTD • Aim: Disease control
Last updated Jun 16, 2026 22:36 UTC
-
New drug trial aims to tame autoimmune diseases
Disease control Not yet recruitingThis study tests a new drug called MTM-H-001 in 75 adults with B-cell-related autoimmune diseases, such as lupus, multiple sclerosis, and rheumatoid arthritis. The goal is to see if the drug is safe and can help control disease activity. Participants will receive the drug in incr…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS (SLE)
Phase: NA • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 08, 2026 13:07 UTC